FDA Approves First Oral Treatment for Postpartum Depression

SILVER SPRING, Md., Aug. 4, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but…